Drug Shortage Report for SANDOSTATIN LAR
| Report ID | 262673 |
| Drug Identification Number | 02239323 |
| Brand name | SANDOSTATIN LAR |
| Common or Proper name | SANDOSTATIN LAR 10MG SYRINGE |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OCTREOTIDE |
| Strength(s) | 10MG |
| Dosage form(s) | POWDER FOR SUSPENSION, SUSTAINED-RELEASE |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | SYRINGE |
| ATC code | H01CB |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2025-07-10 |
| Actual start date | 2025-07-10 |
| Estimated end date | 2025-08-15 |
| Actual end date | 2025-08-13 |
| Shortage status | Resolved |
| Updated date | 2025-11-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-11-04 | French | Compare |
| v3 | 2025-11-04 | English | Compare |
| v2 | 2025-07-14 | French | Compare |
| v1 | 2025-07-14 | English | Compare |
Showing 1 to 4 of 4